These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease. Chiang CH, Chen C, Fang SY, Lin SC, Chen JW, Chang TT. Life Sci; 2023 Aug 15; 327():121863. PubMed ID: 37331504 [Abstract] [Full Text] [Related]
5. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Circ Res; 2015 Jan 30; 116(3):448-55. PubMed ID: 25599331 [Abstract] [Full Text] [Related]
6. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats. Martínez-Rojas MÁ, Balcázar H, Ponce-Nava MS, González-Soria I, Marquina-Castillo B, Pérez-Villalva R, Bobadilla NA. J Physiol; 2024 Apr 30; 602(8):1835-1852. PubMed ID: 38529522 [Abstract] [Full Text] [Related]
10. The interplay between microbiota-dependent metabolite trimethylamine N-oxide, Transforming growth factor β/SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective. El-Deeb OS, Atef MM, Hafez YM. J Cell Biochem; 2019 Sep 30; 120(9):14476-14485. PubMed ID: 31002427 [Abstract] [Full Text] [Related]
11. Diosgenin Reduces Acute Kidney Injury and Ameliorates the Progression to Chronic Kidney Disease by Modifying the NOX4/p65 Signaling Pathways. Chiang CH, Lan TY, Hsieh JH, Lin SC, Chen JW, Chang TT. J Agric Food Chem; 2024 Aug 07; 72(31):17444-17454. PubMed ID: 39074384 [Abstract] [Full Text] [Related]
12. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Xu KY, Xia GH, Lu JQ, Chen MX, Zhen X, Wang S, You C, Nie J, Zhou HW, Yin J. Sci Rep; 2017 May 03; 7(1):1445. PubMed ID: 28469156 [Abstract] [Full Text] [Related]
14. ISG15 accelerates acute kidney injury and the subsequent AKI-to-CKD transition by promoting TGFβR1 ISGylation. Cui N, Liu C, Tang X, Song L, Xiao Z, Wang C, Wu Y, Zhou Y, Peng C, Liu Y, Zheng L, Liu X, Huang K, Chen H. Theranostics; 2024 May 03; 14(11):4536-4553. PubMed ID: 39113797 [Abstract] [Full Text] [Related]
15. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis. Chen DQ, Feng YL, Chen L, Liu JR, Wang M, Vaziri ND, Zhao YY. Free Radic Biol Med; 2019 Apr 03; 134():484-497. PubMed ID: 30716432 [Abstract] [Full Text] [Related]
20. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition. Kim IY, Song SH, Seong EY, Lee DW, Bae SS, Lee SB. Exp Cell Res; 2023 Mar 15; 424(2):113509. PubMed ID: 36773738 [Abstract] [Full Text] [Related] Page: [Next] [New Search]